Shih Alvin
Zevra Therapeutics, Inc. · Director
Shih Alvin is listed in filings as Director at Zevra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 15, 2025, including purchase activity. Recent filings connect the profile to Zevra Therapeutics, Inc. (ZVRA). The current snapshot covers public activity from May 30, 2025 to Sep 15, 2025. Reported amounts are shown as $258.6K to $157.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $158k20k shares | BuySep 12, 2025 | $7.89 | $10.95 |